Defensive Equity Portfolio, Series 44
Ticker Symbol: FSTUDX
|Consumer Staples (49.99%):
||Altria Group, Inc.
||British American Tobacco Plc
||Constellation Brands, Inc.
||Costco Wholesale Corporation
||CVS Health Corporation
||Mondelez International, Inc.
||Monster Beverage Corporation
||Pinnacle Foods Inc.
||Tyson Foods, Inc.
|Health Care (50.01%):
||The Cooper Companies, Inc.
||Edwards Lifesciences Corporation
||HCA Healthcare, Inc.
||Johnson & Johnson
||Novo Nordisk A/S
||Thermo Fisher Scientific Inc.
||UnitedHealth Group Incorporated
* As of the close of business on 3/6/18.
Market values are for reference only and are not indicative of your individual
|Not FDIC Insured Not Bank Guaranteed May Lose Value
|Initial Date of Deposit
|Initial Public Offering Price
||$10.00 per Unit
| Portfolio Ending Date
|Fee Accounts Cash CUSIP
|Fee Accounts Reinvestment CUSIP
|Sales Charges (based on a $10 public offering
|Transactional sales charges:
|Creation and Development Fee:
|Maximum Sales Charge:
The deferred sales charge will be deducted in three monthly installments commencing
When the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If
the price exceeds $10.00 per unit, you will pay an initial sales charge.
|Maximum Sales Charge:
The maximum sales charge for investors in fee accounts consists of the creation and development fee.
Investors in fee accounts are not assessed any transactional sales charges. Standard accounts sales charges
apply to units purchased as an ineligible asset.
The creation and development fee is a charge of $.050 per unit collected at
the end of the initial offering period. If the price you pay exceeds $10.00 per
unit, the creation and development fee will be less than 0.50%; if the price
you pay is less than $10.00 per unit, the creation and development fee will exceed
In addition to the sales charges listed, UITs are subject to annual operating expenses and organization costs.
You should consider the portfolio's investment objective, risks, and
charges and expenses carefully before investing. Contact your financial advisor
or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus,
which contains this and other information about the portfolio. Read it carefully
before you invest.
An investment in this unmanaged unit investment trust should be made with an
understanding of the risks involved with owning common stocks, such as an economic
recession and the possible deterioration of either the financial condition of
the issuers of the equity securities or the general condition of the stock market.
You should be aware that the portfolio is concentrated in stocks in both the
consumer products and health care sectors which involves additional risks, including
limited diversification.The companies engaged in the consumer products industry
are subject to global competition, changing government regulations and trade
policies, currency fluctuations, and the financial and political risks inherent
in producing products for foreign markets.The companies engaged in the health
care sector are subject to fierce competition, high research and development
costs, governmental regulations, loss of patent protection, and changing consumer
An investment in a portfolio containing equity securities of foreign issuers
is subject to additional risks, including currency fluctuations, political risks,
withholding, the lack of adequate financial information, and exchange control
restrictions impacting foreign issuers.
An investment in a portfolio containing small-cap and mid-cap
companies is subject to additional risks, as the share prices of
small-cap companies and certain mid-cap companies are often
more volatile than those of larger companies due to several
factors, including limited trading volumes, products, financial
resources, management inexperience and less publicly
This UIT is a buy and hold strategy and investors should consider their ability to hold the trust until maturity. There may be tax consequences unless units
are purchased in an IRA or other qualified plan.
The value of the securities held by the trust may be subject to steep declines
or increased volatility due to changes in performance or perception of the issuers.